Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Hematology|September 15, 2020
Expert consensus regarding standardization of sample preparation for clotting time assaysMasahiro Ieko, Yutaka Komiyama, Satoshi Yamazaki, et al.
Cancer Science|October 10, 2020
Efficacy of the novel tubulin polymerization inhibitor PTC-028 for myelodysplastic syndromeCheng Zhong, Kensuke Kayamori, Shuhei Koide, et al.
Cancer Biomarkers : Section a of Disease Markers|April 11, 2016
Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromesSumiko Kobayashi, Yasunori Ueda, Yasuhito Nannya, et al.
International Journal of Hematology|July 31, 2019
Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromesHiroshi Kawabata, Kensuke Usuki, Maki Shindo-Ueda, et al.
International Journal of Hematology|May 13, 2017
Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registryHiroshi Kawabata, Kaoru Tohyama, Akira Matsuda, et al.
Leukemia Research|June 20, 2018
Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: From the Japanese central review studyAkira Matsuda, Hiroshi Kawabata, Kaoru Tohyama, et al.
Scientific Reports|January 27, 2021
Clonal hematopoiesis in adult pure red cell aplasiaNaohito Fujishima, Junki Kohmaru, Souichi Koyota, et al.
Blood Advances|January 26, 2021
DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromesKensuke Kayamori, Yurie Nagai, Cheng Zhong, et al.
British Journal of Haematology|January 31, 2024
Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registryTomoya Maeda, Akira Matsuda, Junya Kanda, et al.
Oncotarget|November 5, 2017
Oxidative stress-induced JNK/AP-1 signaling is a major pathway involved in selective apoptosis of myelodysplastic syndrome cells by Withaferin-AKarine Z Oben, Sara S Alhakeem, Mary K McKenna, et al.
Pageof 10